Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pediatrix
NCT06015191 · Congenital Heart Disease in Children
NCT06918795 · Single-ventricle, Congenital Heart Disease
NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more
NCT05647213 · Univentricular Heart, Congenital Heart Disease, and more
NCT07114718 · Congenital Heart Disease, Congenital Heart Disease (CHD)
Capital Health Regional Medical Center - Pediatrix Medical Group
Trenton, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions